Pharma

I spent 3 days with pharma executives. They're suddenly taking longevity seriously.

I spent 3 days with pharma executives. They're suddenly taking longevity seriously.

Big Pharma's China deal spree grows with latest tie-up worth up to $7.8 billion

Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.

Johnson & Johnson vs. Eli Lilly: Which Pharma Stock Can Make Your Portfolio Healthier in 2026?

JNJ trades at a 28% discount on valuation while LLY's cardiometabolic drugs drive 82% of revenue, each bet carries distinct growth and concentration risks.

Pharma stock soars 150% on injectables deal with Wegovy maker Novo

Shares in Swedish microcap stock Nanexa more than doubled after the drug-delivery group revealed a licensing deal with European pharma giant Novo Nordisk.

Does iShares Pharma ETF Offer Superior Returns to Invesco's Equal Weight Healthcare Fund?

IHE's concentrated pharma holdings delivered 50% returns over one year, while RSPH's equal-weight healthcare approach generated 29%. Risk profiles differ sharp…

Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026?

IHE's concentrated pharma focus delivered 50% gains versus IYH's 27.4%, though the broader healthcare fund offers more diversification and $3.9B in assets.

Invesco Pharmaceuticals vs iShares Healthcare: Which Healthcare ETF Brings Better Profits

Invesco's concentrated 30-stock pharma fund delivered 43.1% returns last year, but iShares' broader 100-holding portfolio costs less and offers wider sector ex…

'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat

Sandoz CEO Richard Saynor warns steep U.S. tariffs on imported generic drugs could force manufacturers to raise prices or cut supply.

Pharma major Novartis falls nearly 10%, heading for worst day on record after three drug trial setbacks

Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.

What's Fresh in the AstraZeneca (LSE:AZN) Story This Week?

AstraZeneca (LSE:AZN) is drawing fresh attention across the London market as the pharma major setting the tone for UK blue-chip resilience shapes the read agai…

Candace Owens BLAMES Big Pharma In Lindsay Clancy Case, Tim Pool AGREES

Candace Owens BLAMES Big Pharma In Lindsay Clancy Case, Tim Pool AGREES

Will Pharma and Specialty Demand Boost Cardinal Health's Q4 Results?

Eli Lilly is reinventing the pharma business

The world's largest drugmaker is betting big on preventive medicines - and learning from big tech

AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?

AbbVie and Pfizer are taking divergent paths to navigate patent expirations and competition. Dig into their financials, risk profiles, and valuation metrics.

Biotech IPO window is opening but big pharma M&A still leaders, top bankers say

Biopharma dealmaking is driven by pressure to top up drug pipelines ahead of major patent expirations later this decade.

Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology

U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it…

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

Companies see a commercial opportunity in creating new ways to administer drugs to patients - in space.

Pharma stocks are showing strength. Charts predict this name could break out next

Pharmaceutical stocks have recently separated themselves from the broader market, and the group has become a source of leadership within healthcare.

Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial

The drugmaker's shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.

Should Big Pharma Be Banned From TV Ads?

Should Big Pharma Be Banned From TV Ads?

Health Expert - Secrets Big Pharma Doesn't Want You To Know | PBD #801

Health Expert - Secrets Big Pharma Doesn't Want You To Know | PBD #801

LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma

SEOUL, South Korea, May 17, 2026 /PRNewswire/ -- LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo P…

Hot Picks: Pharma stocks gain on obesity drug demand

Pharma stocks are gaining momentum as obesity drugs, oncology therapies and biotech innovation boost investor optimism.

Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer's Disease

SHANGHAI and SEONGNAM, South Korea, May 13, 2026 /PRNewswire/ -- On 13 May, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196…

OxyContin maker Purdue Pharma's settlement, by the numbers

OxyContin maker Purdue Pharma's deal to resolve thousands of lawsuits over the toll of opioids is taking effect Friday and the company is being replaced by a n…

Pharma Giant Purdue Sentenced To $5.5 Billion For 'Fueling The Opioid Epidemic'

'Putting countless lives at risk'

Purdue Pharma to be dissolved as judge approves criminal sentence in opioid case

OxyContin maker to be replaced by new company aiming to combat opioid crisis as legal settlement takes effect. OxyContin maker Purdue Pharma is set to be disso…

Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement

Purdue Pharma was sentenced Tuesday to $5.5 billion in fines and penalties on charges of deceiving regulators and paying doctors to boost opioid sales.

Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal

To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.…

Purdue Pharma expected to forfeit $225m as sentence in criminal opioids case

Under settlement, Sackler family will pay state, local and Native American tribal governments, individual victims and others. Sign up for the Breaking News US…